Related by context. All words. (Click for frequent words.) 72 characterizing activators 61 JAK2 inhibitor 60 molecular biomarkers 58 small molecule modulators 58 cardiac muscle contractility 58 JAK1 58 small molecule agonists 57 antisense inhibitors 57 oral Janus kinase 57 peptidic compound 57 Protein Kinase C 57 adenosine A2A 57 oral prodrug 57 neuronal nicotinic receptors NNRs 57 small molecule activators 56 targeting PCSK9 56 novel peptide 56 prostaglandin synthesis 56 G Protein Coupled 56 protein tyrosine phosphatases 56 inhibit KSP 56 histone deacetylase HDAC 56 RAF kinase VEGFR 56 thromboxane A2 56 intracellular signaling pathways 56 lipid particles SNALP 56 investigational humanized monoclonal antibody 56 NTDDS 56 immune modulation 56 Factor VIIa 56 Tß4 56 leukotriene pathway 55 hedgehog pathway 55 RNAi therapeutic targeting 55 gastro intestinal inflammation 55 ALN TTR# 55 identify protein biomarkers 55 selectively induce apoptosis 55 Wnt signaling pathway 55 pharmacological chaperone 55 Vascular Endothelial Growth 55 small molecule defensin 55 mitotic kinesins 55 IAP inhibitors 55 protein misfolding 55 hyperphosphorylation 55 Personalized Immunotherapy 55 JAK2 enzyme 55 insulin sensitizing agents 55 biased ligand 55 DNA methyltransferases 55 IAP inhibitor 55 engineered RAP peptides 55 3 kinase PI3K 55 humanized anti 54 novel anti infective 54 enhance ApoA 54 MEK inhibitor 54 Squalamine 54 diagnostic biomarkers 54 RNAi therapeutic targeting PCSK9 54 oncolytic viruses 54 Receptors GPCRs 54 nicotinic alpha 7 54 romazarit 54 either acutely decompensated 54 TLR8 54 IL #p# 54 small molecule inhibitors 54 FGFR 54 ALN PCS 54 p# inhibitor 54 selective inhibition 54 Fc fusion protein 53 isoform selective 53 c Raf kinase 53 ALN TTR 53 kidney urologic 53 proliferative diseases 53 FOLOTYN ® 53 FGFs 53 HMG CoA 53 NuMimetic TM 53 CD# CEA 53 selective androgen receptor modulators 53 Solazed TM 53 pyrimidine 53 immunoregulatory 53 ZFP Therapeutic 53 immuno inflammatory 53 preclinical studies 53 Smac mimetics 53 AKIP ™ 53 GGF2 53 siRNA conjugates 53 predictive biomarkers 53 EGFR pathway 53 CYP#A# CYP#D# 53 peptibody 53 VitiGam 53 targeted radiotherapeutic 53 Symadex 53 immuno inflammatory diseases 53 CEQ# 53 ArQule Kinase Inhibitor 53 positive inotropic agents 53 DNAi 53 CCR9 antagonist 53 myelofibrosis polycythemia vera 53 Fibroblast Growth Factor Receptor 53 CYT# potent vascular disrupting 53 coronary vasodilation 53 P#X# 53 cardiac contractility 53 Hybridon 53 PNP inhibitor 53 Viprovex TM 53 molecular imaging radiopharmaceutical 53 biologic therapeutics 53 sd rxRNA compounds 53 Alzheimer disease cognitive impairment 52 5 HT2A serotonin 52 P#X# antagonist 52 PDE# inhibitors 52 cytolytic 52 antisense oligonucleotides 52 Nasdaq HALO biopharmaceutical 52 PI3K/mTOR 52 SARMs 52 NASDAQ SNTA 52 Delta opioid receptor 52 otelixizumab 52 siRNA therapeutics 52 AAG geldanamycin analog 52 histone deacetylase 52 ArQule Kinase Inhibitor Platform 52 RNA antagonist 52 pan HDAC inhibitor 52 AEG# 52 HepDirect technology 52 belinostat 52 Ibis T# TM 52 Brussels THR 52 therapeutic peptide 52 NASDAQ SNTA biopharmaceutical 52 Addex Pharmaceuticals www.addexpharma.com discoverMunsif Khan spokesman 52 synthetic cannabinoid compounds 52 molecular chaperone 52 Homspera TM 52 stable nucleic acid 52 hypoxia activated prodrug 52 ALN HPN 52 HepDirect R 51 mu opioid receptor antagonist 51 PI3 kinase inhibitors 51 Ampakine compounds 51 engineered proteases 51 optimal dosing regimens 51 inhibitor PPI 51 novel orally administered 51 cardiometabolic disorders 51 microRNA therapeutics 51 monoclonal antibody therapeutics 51 multi kinase inhibitor 51 MTP inhibitor 51 ALN VSP 51 PDGF receptor 51 preclinical 51 Locked Nucleic Acid 51 novel immunotherapies 51 sulfatase 51 HuLuc# 51 commercializing anti infective 51 validating biomarkers 51 Nanobody ® 51 immunological diseases 51 mda 7 51 PROT biotechnology 51 DPX Survivac 51 Genaera Corporation 51 substrates inhibitors 51 Morria Biopharmaceuticals Plc 51 AVEO Pharmaceuticals Inc. 51 THR beta agonist 51 NNRs 51 Nonsteroidal anti inflammatory 51 NFkB 51 neuro inflammatory 51 vaccine GRNVAC1 51 Injury ALI 51 cyclooxygenase 51 beta blockers calcium 51 tiapamil 51 novel RNAi therapeutics 51 investigational monoclonal antibody 51 Pentad TM 51 potently inhibit 51 toxic amyloid beta 51 IR BioSciences Holdings 51 Announces Poster Presentations 51 investigational therapies 51 vascular disrupting agent 51 immunologic diseases 50 glucocorticoid receptors 50 Curaxin CBLC# 50 preclinical compounds 50 siRNA therapeutic 50 drugable targets 50 KineMed 50 novel therapeutics 50 Archemix Corp. 50 IIB ActRIIB 50 selective inhibitors 50 Inc. Nasdaq NLTX 50 purinergic receptors P#X# 50 infectious diseases autoimmune 50 DiLA2 50 Curaxins 50 A3 adenosine receptor 50 florbetaben 50 Oracea TM 50 overactivation 50 neurodegenerative diseases Alzheimer disease 50 psoriasis rheumatoid arthritis 50 collagen deposition 50 INS# [001] 50 ATL# [001] 50 Nasdaq RXII 50 commercializing therapeutic 50 TLR9 agonists 50 skeletal muscle contractility 50 ZFP TF 50 rxRNA 50 anticancer therapeutics 50 Aganocide ® 50 DOS# 50 regulate therapeutically important 50 Familial Adenomatous Polyposis FAP 50 autoimmune uveitis 50 novel peptides 50 DURECT proprietary 50 rheumatoid arthritis multiple sclerosis 50 YM AIM YMBA 50 Nasdaq HALO 50 fatty acid amide hydrolase 50 ELADUR ™ 50 small molecule therapeutics 50 pralatrexate injection folate analogue 50 LNP formulations 50 Pyridorin 50 novel immunotherapeutic 50 regenerative therapies 50 antiviral compounds 50 OTCBB CHKT biotechnology 50 genomic biomarker 50 candidates Azedra TM 50 small molecule 50 prostanoid 50 AMEX REX 50 ankyrin repeat 50 CD# expressing 50 histone methyltransferases HMTs 50 novel antiviral therapeutics 50 ALN HTT 50 glitazone class 50 increasing cardiac contractility 49 immunotherapeutics 49 N methyl 49 OTCBB CVBT 49 antisense drug 49 Spiegelmers ® 49 Archexin 49 ZFN TM 49 Stapled Peptide 49 fibrotic disease 49 Initiates Phase II 49 HIF biology 49 myeloproliferative disorders 49 novel antibody therapeutics 49 Selective Electrochemical Tumor Ablation 49 AMPK activators 49 cholesteryl ester transfer 49 Nasdaq MYRX 49 RNAi therapeutic 49 carbohydrate polymers 49 adrenergic regulation 49 CYT# novel 49 Listeria vaccine 49 statins fibrates 49 intracellular protein 49 Nanobody 49 CYP #A# 49 Tumour Vascular Disrupting Agent 49 orally bioavailable mimics 49 cytoskeleton enables 49 Nasdaq MITI biopharmaceutical 49 prescribed proton pump 49 Locked Nucleic Acid LNA 49 OTCBB HPLF FWB HL1 49 RAS RAF MEK ERK 49 Combivir Kivexa 49 mTOR kinase 49 Akesis Pharmaceuticals 49 Ore Pharmaceuticals 49 novel therapeutic antibodies 49 product platforms AZX# 49 M2 subunit 49 PsychoGenics 49 HCV polymerase inhibitors 49 Amex PTN 49 NovaBay Aganocide compounds 49 Frankfurt XMP 49 Adnectin 49 neuroprotective properties 49 Cellgate Inc. 49 therapeutic monoclonal antibodies 49 GED aPC 49 PDE7 49 NNR Therapeutics 49 peptide therapeutics 49 Sangamo BioSciences 49 glucocerebroside primarily 49 www.ucb group.com 49 intracellular pathway 49 endocrine diseases 49 druggable targets 49 novel immunomodulatory 49 rusalatide acetate 49 therapeutic monoclonal antibody 49 fibrotic disorders 49 HepDirect 49 Anticalins R 49 theranostic 49 investigational compounds 49 sodium thiosulfate STS 49 DsiRNA 49 Inc. Nasdaq IMGN 49 humanized antibodies 49 preclinical models 49 nephrology oncology supportive 49 oral ghrelin agonist 49 inhibit metastasis 49 peptide peptide mimetic 49 sd rxRNA 48 oral JAK#/JAK# inhibitor 48 AVXL 48 POSIDUR TM ELADUR TM 48 prognostic biomarker 48 Hedgehog pathway 48 autoimmune inflammatory 48 cardiovascular metabolic 48 microRNA biomarkers 48 including thyroiditis RA 48 Angiocept 48 transthyretin TTR mediated amyloidosis 48 ErbB3 HER3 48 Prodarsan R 48 Therapeutic Competitors Companies 48 Nile Therapeutics 48 Nasdaq ASTM 48 ELND-#/AZD-# 48 hepatitis C polymerase 48 Akebia Therapeutics 48 commercializing novel biotherapeutics 48 Inc. AMEX YMI 48 platform HDL Mimetic 48 Enkephalin 48 Myrexis Inc. 48 commercialize microRNA therapeutics 48 blood serum biomarkers 48 exon skipping 48 DNA methylation biomarkers 48 receptor partial agonist 48 Survivin antagonist 48 Omeros Corporation 48 Unit Dose Budesonide 48 pancreatic alpha 48 CRMD pharmaceutical 48 skeletal muscle weakness 48 selectively inhibit 48 cancer immunotherapies 48 toxigenic Clostridium difficile 48 Gemin X 48 ophthalmic diseases 48 molecular abnormalities 48 inflammatory diseases 48 lead molecular radiotherapeutic 48 Nasdaq IDRA today 48 NASDAQ AVEO biopharmaceutical 48 antiangiogenesis therapies 48 Microplasmin 48 Akt signaling 48 demonstrated anti amnesic 48 Spiegelmers R 48 fibrotic diseases 48 Celator 48 GlycoPEGylated hemostasis compounds 48 Nasdaq ENMD 48 acetonide FA 48 polyneuropathy HIV DSP 48 molecular radiotherapeutics 48 Curaxin 48 genomic biomarkers 48 Provectus Pharmaceuticals specializes 48 OTCBB NRGX 48 aptamers 48 PPAR peroxisome proliferator activated 48 ALV# 48 antisense drugs 48 epothilones 48 fusion proteins 48 OTCBB NRGX biotechnology 48 sirtuin therapeutics 48 dermatology therapies 48 Genasense evaluating 48 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 48 Acute Lung 48 gastrointestinal mucositis 48 ABLYNX 48 Trophos 48 siRNA compounds 48 OTCBB IMNR 48 CNS disorders 48 CB2 selective 48 OTCBB PYTO 48 diabetic nephropathy 48 Rosetta Genomics microRNA 48 TSX VIR 48 Onalta 48 Receptos 48 TSX CTI 48 Nasdaq MNKD focused 48 OTCBB CHKT 48 Hsp# inhibition 48 CHDI Foundation 48 Ception Therapeutics 48 epigenetic enzymes 48 OTCQB CTIX 48 HMG CoA reductase inhibitors 47 beta secretase inhibitors 47 Genetic variations 47 cortisol synthesis 47 NYSE Amex PBTH 47 migraines neurorehabilitation 47 #/#/# Cytokinetics Incorporated 47 customizable drug eluting 47 Xytis 47 lipid nanoparticles 47 Adrian Hobden Ph.D. 47 acne impetigo 47 factor receptor FGFR 47 lysosomal 47 Cyclooxygenase 2 47 neuropathic pain metabolic diseases 47 protein kinase inhibitors 47 GAP #B# 47 Sphingomab TM 47 molecular imaging radiopharmaceuticals 47 VIA Pharmaceuticals 47 Chemokine Therapeutics 47 Nasdaq PARD 47 infectious diseases autoimmune diseases 47 TRACON Pharmaceuticals 47 gene loci 47 vitreoretinal disorders 47 ophthalmology dermatology cardiovascular disease 47 liposomal delivery 47 allosteric modulation 47 OGeS 47 Syndax Pharmaceuticals Inc. 47 cromolyn sodium 47 Tβ4 47 R Saizen R 47 systemic RNAi 47 OTCBB IMUC 47 kinase inhibitor 47 pRb 47 NYSE Amex PTN 47 nitric oxide synthase NOS 47 molecular chaperone regulation 47 cognitive impairment associated 47 proprietary PEGylation 47 Azedra 47 Regado Biosciences 47 ARRY # 47 RNA interference RNAi therapeutics 47 TSX YM AIM 47 MyVax ® 47 MDRNA proprietary 47 Nasdaq OMER 47 sd rxRNA ™ 47 Agios Pharmaceuticals 47 cellular immunotherapy 47 epigenetic regulation 47 commercialize microRNA 47 delivered RNAi therapeutic 47 TSX VENTURE GAP 47 multiprotein complex 47 recombinant plasma 47 humanized monoclonal antibodies 47 tkRNAi 47 pharmacological chaperones 47 ostarine 47 Promedior 47 LentiVector technology 47 BHT DNA 47 humanized monoclonal antibody 47 novel kinase inhibitors 47 oligonucleotide therapeutics 47 Oxis International 47 Nasdaq IDRA 47 immunotherapeutic approaches 47 Viprovex R 47 ADVEXIN p# therapy 47 Protalex Inc. 47 advancing novel biotherapeutics 47 sirtuin inhibitor program 47 predictive biomarker 47 initiated Phase 1b 47 non alcoholic steatohepatitis 47 pharmacogenetic test 47 ophthalmology oncology 47 Nasdaq DYAX 47 Nanotope 47 anticoagulant reversing agent 47 Aviptadil 47 Response Genetics Inc. 46 MAbs targeting 46 clinically validated targets 46 vaccines oncolytic virus 46 Inc. Nasdaq RNVS 46 AV HALT 46 genomic alterations 46 BXT # 46 PI3K/Akt pathway inhibitor 46 miRNA therapeutics 46 AtuPLEX 46 endophenotypes 46 rxRNA compounds 46 Nasdaq OMER biopharmaceutical 46 resolvin 46 HSP# inhibitors 46 Drew Fromkin President 46 NASDAQ EMIS 46 DNA methylation patterns 46 NasdaqGM SPPI commercial 46 KL4 surfactant 46 mineralocorticoid 46 RECOTHROM ® 46 epigenetic therapeutics 46 ETBs 46 OTCBB NVLT biopharmaceutical 46 anticancer compounds 46 Spiro Rombotis President 46 AEMD 46 theranostics 46 OTCBB HXBM developer 46 XSSE OXGN 46 Prodarsan ® 46 OTCBB QTXB 46 NASDAQ OPXA 46 buccal delivery 46 anti infective treatments 46 oncology therapeutics 46 HepaLife Technologies Inc. 46 MyVax R 46 San Diego Amira Pharmaceuticals 46 PLK1 SNALP 46 TSX VENTURE DMA 46 Cytogen marketed 46 Factor VIIa Factor VIII 46 RNA therapeutics 46 immatics 46 Ceregene 46 derivatives Radilex TM 46 tranilast 46 Alvine Pharmaceuticals 46 4SC AG ISIN DE# 46 NYSE Amex RGN 46 ImmuneRegen BioSciences Inc. 46 cardio renal 46 Intarcia 46 cholesterol ester 46 ribonucleotide reductase clinically validated 46 Nasdaq ALNY 46 PROfusion 46 XmAb ® 46 StromaCel Inc. 46 antibacterial therapeutics 46 Memryte 46 EPIX Pharmaceuticals Inc. 46 converting enzyme 46 NASDAQ ABII 46 KL4 Surfactant 46 Biosensor System revolutionary 46 coronary stent merged 46 therapeutic antibody 46 NYSE Amex AEN 46 Pervasis 46 LibiGel NDA 46 L BLP# 46 REGENERX BIOPHARMACEUTICALS INC. 46 SGLT inhibitors 46 Tekmira Pharmaceuticals Corporation 46 NASDAQ INGN 46 commercializing oxidized glutathione 46 monocytogenes Listeria vaccines 46 CCR1 46 CIN lesions pre 46 vascular disorders 46 Kari Stefansson CEO 46 NASDAQ ALTH biopharmaceutical 46 SNALP technology 46 thetreatment 46 Nasdaq IDIX 46 LNPs 45 DiLA2 platform 45 NEUGENE R 45 Avila Therapeutics 45 polycystin 45 Affimed Therapeutics AG 45 brain neurotransmitter 45 prognostic biomarkers 45 Nasdaq VRTX 45 COVER YOUR BODY 45 anticancer agents 45 Nasdaq IDIX biopharmaceutical 45 Inc. Nasdaq ALNY 45 ADME properties 45 PEGylation 45 ImmuneY2 45 inhibitor rofecoxib 45 Azixa 45 Inc. Nasdaq INFI 45 metabolic disorders 45 5 HT1A receptor 45 rxRNA ™ compounds 45 targeted covalent 45 autologous cell 45 enzyme NADPH oxidase 45 neurodegenerative disorders 45 Antithrombin 45 therapeutics 45 neurodegenerative diseases 45 metabolomic profiling 45 Inc. Nasdaq CYCC 45 delay bone metastases 45 Inc. NASDAQ AGIX 45 PRNewswire FirstCall YM BioSciences 45 Uli Hacksell Ph.D. 45 detoxify harmful 45 immunotherapy treatments 45 glial derived neurotrophic 45 commercialize deforolimus 45 Cellzome 45 Avian Transgenic Technology 45 proprietary biomaterials 45 autism susceptibility genes 45 protein misfolding diseases 45 Inc. OTCBB IRBS 45 Quark Biotech Inc. 45 aptamer therapeutics 45 Aerie Pharmaceuticals 45 Adeona Pharmaceuticals Inc. 45 MEK inhibitors 45 Opexa Therapeutics Inc. 45 prostone 45 OTCBB DORB 45 Board LWLG technology 45 Enhanze TM Technology 45 NovaBay Pharmaceuticals 45 JAK2 kinase 45 Novosom 45 therapeutic peptides 45 embryonic germ 45 cancer therapeutics 45 commercializing aptamer therapeutics 45 biased ligands 45 degenerative disorders 45 Nasdaq GENR 45 OTCBB DORB DOR 45 PRNewswire FirstCall Nastech Pharmaceutical 45 retinal disorders 45 developing chemokine 45 investigational pan BCR 45 Inc. NASDAQ IDMI 45 Sangamo ZFP technology 45 cytokines chemokines 45 Neuraltus 45 underlying mechanisms Conney 45 antisense therapeutics 45 Logical Therapeutics 45 MPH AMEX 45 dermal tissues keratinocyte migration 45 antibody therapeutics 45 taste modulators 45 oxidase 45 osteolytic bone disease 45 diseases fat malabsorption 45 Adenosine Therapeutics 45 OTCBB INSV 45 Æterna Zentaris Inc. 45 dermatological diseases 45 PLX MS 45 HDAC inhibitor 45 renin inhibition promising 45 SMARTICLES ® 45 Therapeutic antibodies 45 disease modifying 45 Ph.D. Targacept 45 Friedreich Ataxia FRDA 45 diabetic retinopathy DR 45 FoldRx Pharmaceuticals Inc. 45 diphosphate 45 autoimmune diseases 45 NASDAQ EPIX 45 Inc. Nasdaq VIAP 45 biomarker 44 Inc. OTCBB ECTE 44 immuno pharmaceutical 44 MP4 molecule 44 Inc. NASDAQ AEZS 44 nickname Abu Laith 44 OMRIX Biopharmaceuticals Inc. 44 Ligand proprietary 44 Cynapsus formerly 44 commercialize Aganocides 44 NYSE Amex RNN 44 Salmonella vector 44 CAMBRIDGE Mass. Alnylam Pharmaceuticals 44 herpes simplex viruses 44 symbol AVXL 44 Charlesson 44 protein CETP 44 autologous cellular therapy 44 Dehydrogenase 44 Nasdaq ENZN 44 Hepatitis C Virus HCV 44 super oxide dismutase 44 Inc. Nasdaq ONTY 44 monoclonal antibody 44 OTCBB CTIX 44 Decoding genome 44 biomarkers 44 adrenal hormones 44 causative mutations 44 CONTAIN FORWARD LOOKING STATEMENTS 44 renal tubular 44 polymerase inhibitors 44 Zymeworks 44 Nasdaq KOSN 44 Ltd. OTCBB IMUC 44 Immtech Pharmaceuticals Inc. 44 liposomal formulations 44 AAV vector 44 metabonomics 44 therapeutic antibodies 44 superior ophthalmologic products 44 targeted diseased tissues 44 Nasdaq MBRX announced 44 MOVE IN TANDEM 44 Myolimus 44 regenerating bone 44 xerostomia secondary 44 Revimmune TM 44 topical anti infective 44 AB OMXS BINV 44 Ostabolin C TM 44 PRNewswire FirstCall Neurogen 44 efficacious treatments 44 FoldRx 44 Fleximer 44 TTR amyloidosis 44 mRNA sequences 44 siRNA delivery 44 oncolytic 44 novel peptide therapeutics 44 Parkinson disease Alzheimer disease 44 Celsion Corporation 44 stratifying patients 44 Neuro Hitech 44 Serostim R 44 human antibody therapeutics 44 covalent drugs 44 NASDAQ LGND 44 protein biomarkers 44 NovaBay Pharmaceuticals Inc. 44 selective angiogenic kinase inhibitor 44 Mycobacterium tuberculosis MTB 44 Nasdaq CYTR biopharmaceutical 44 modified glutathione analog 44 Phenomix Corporation 44 epilepsy Parkinson disease 44 systemic lupus erythematosus psoriasis 44 IXSBF 44 Monopril 44 ANAVEX 44 antibody fragment therapeutics 44 Transdel Pharmaceuticals Inc. 44 ANTICIPATES TARGETS GOALS PROJECTS 44 Nasdaq LXRX biopharmaceutical 44 proteosome 44 PluriCells TM 44 Metabasis Therapeutics Inc. 44 Novelos Therapeutics Inc. 44 biomarker assays 44 NASDAQ TGEN 44 Xenon Pharmaceuticals 43 Nasdaq FOLD 43 NASDAQ ZIOP announced 43 Galenea 43 live attenuated Listeria 43 recombinant vaccines 43 posttranslational modifications 43 Inc. OTCBB OXIS 43 renal excretion 43 cardiovascular disorders 43 Locus Pharmaceuticals 43 Applied NeuroSolutions 43 renal diseases 43 TSX ONY 43 oncology indications 43 Neurogen Corporation 43 kinase inhibitors 43 Nitric Oxide Synthase 43 A1PI 43 inflammatory autoimmune 43 AWAY FROM WINDOWS 43 ACC2 43 Boniva ibandronate 43 Phosphodiesterase 43 Stargardt Macular Dystrophy 43 IS WHERE IS 43 novel anticancer therapies 43 Etubics 43 OTC BB PVCT 43 Photodynamic Therapy PDT 43 SIDE EFFECTS CHEAP ONLINE 43 ocular diseases 43 Neogenix 43 PROLOR Biotech Inc. 43 diabetes irritable bowel 43 treat gastrointestinal disorders 43 Inc. Nasdaq AVRX 43 rennin 43 anticancer therapies 43 neovascular diseases 43 ocular infections 43 metabolic diseases 43 NasdaqCM PSTI DAX PJT 43 ASONEP TM 43 OTCBB PYTO FWB ET6 43 TOPIGEN 43 hematologic disorders 43 therapeutic modality 43 ZANAFLEX CAPSULES ® tizanidine 43 targeted immunotherapies 43 NYSE Amex NBY clinical 43 Amex KAL 43 Pervasis Therapeutics Inc. 43 Nasdaq RGDX 43 pharmacogenomic tests 43 NASDAQ PPHM clinical 43 AVANIR Pharmaceuticals Inc. 43 RONDEL ™ 43 Cynapsus Therapeutics Inc. 43 DermTech 43 nonhematologic adverse reactions 43 photodisinfection 43 NASDAQ BTRX pharmaceutical 43 Ser# 43 Aradigm Corporation 43 DOR BioPharma Inc. 43 adrenal steroid hormones 43 OTCBB VCRT 43 antiviral therapeutics 43 Nasdaq AEZS 43 NASH Huntington 43 selective kinase inhibitors 43 Tranzyme 43 TSX AHX 43 commercializes therapeutics 43 Bioral 43 Pulmo BioTech Inc. 43 Lipid Sciences Inc. 43 positional cloning 43 deCODE Genetics Illumina Navigenics 43 genetic loci 43 neuroblocking technology 43 targeted anticancer biopharmaceuticals 42 autoimmune indications 42 Nasdaq TARG 42 Nicholas Katsanis Ph.D. 42 Dr. Aiping Young 42 Sangamo BioSciences Inc. 42 diclofenac Voltaren 42 Fibrocell Science 42 AMEX KAL 42 Mesoblast Limited ASX MSB 42 NATIONAL STEAK AND POULTRY 42 neoplastic transformation 42 intracellular calcium 42 Inc. NASDAQ CRIS 42 REMOXY ® 42 RNAi molecules 42 indications contraindications 42 orally administered pharmacological chaperones 42 therapies 42 Unigene Laboratories Inc. 42 QuantRx Biomedical Corporation 42 Nastech Pharmaceutical Company 42 proinflammatory 42 proteomic profiling 42 OTCBB TDLP 42 neuromodulation therapies 42 targeted radiotherapeutics 42 glycan microarray 42 Corporation Nasdaq CRGN 42 NASDAQ CYTR biopharmaceutical 42 OTCBB OHRP 42 ImmunoCellular Therapeutics Ltd. 42 anti infective compounds 42 Huntingtons disease 42 ChemoCentryx 42 MYH9 gene 42 WiseAnalytics Lyndsay Wise 42 TSX VENTURE KNE biotechnology 42 OTCBB PVCT 42 MTHFD1L 42 TorreyPines Therapeutics Inc. 42 Rhucin ® recombinant 42 innovative signaling pathway 42 imaging radiopharmaceuticals 42 personalized cellular immunotherapy 42 ribosomal RNA rRNA 42 Calistoga Pharmaceuticals 42 Hana Biosciences 42 ATTR PN 42 lgierer@ledger-enquirer.com 42 splice junctions 42 beta adrenergic receptor agonists 42 Supernus Pharmaceuticals 42 EyeGate 42 NYSE Alternext ULU 42 pre malignant lesions 42 J Am Soc 42 CombinatoRx 42 phosphate dehydrogenase 42 NeuroMedix 42 neuro degenerative diseases 42 bio therapeutics 42 systemic RNA interference 42 immunologically matched 42 infectious autoimmune 42 VentiRx 42 Phospholipase A2 42 RNAi therapeutics 42 alferminogene tadenovec 42 Nasdaq PARD biopharmaceutical 42 Ibis T# 42 OTCBB FCSC 42 BACcelr8r TM 42 ORMDL3 42 Akela Pharma Inc. 42 secrete molecules 42 Company Nasdaq RGDX 42 pharmacogenomic 42 Epeius Biotechnologies Corporation 42 Nephrol 42 topically delivered 42 Polycomb proteins 42 Dynavax Technologies Corporation 42 pathological angiogenesis 42 Inc. OTCBB SNWV 42 Kleanthis G. Xanthopoulos Ph.D. 42 regenerative medicine 42 Edward Lanphier Sangamo 42 biologically validated targets 42 catalytic antioxidant compounds 41 OTCQB ABPI 41 activity dependent neurotrophic 41 genomic transcriptomic 41 opioid agonists 41 etiological 41 Urigen Pharmaceuticals Inc. 41 ophthalmic therapeutics 41 OSI Prosidion 41 companion diagnostics 41 NASDAQ EPIX biopharmaceutical 41 Biomoda www.biomoda.com 41 NASDAQ AEZS TSX AEZ 41 Dicer Substrate Technology 41 mGluR4 mGluR2 41 Adherex Technologies Inc. 41 Nasdaq TGEN 41 Nasdaq IMGN 41 Accurately identifying 41 immunotherapies 41 Inc. NASDAQ NLTX